Reduced-intensity stem cell transplantation in two cases of metastatic renal cell carcinoma

International Journal of Urology

Volumn 10, Issue 11, 2003, Pages 610-614

  Aoyama, Yasutaka ^a   Nakamae, Hirohisa ^a   Yamamura, Ryousuke ^a   Makita, Kaori ^a   Shima, Etsuko ^a   Ohta, Kensuke ^a   Takubo, Takayuki ^a   Yamane, Takahisa ^a   Sugimura, Kazunobu ^a   Kawashima, Hideknori ^a   Nakatani, Tatsuya ^a   Hino, Masayuki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Allogeneic stem cell transplantation; Graft versus tumor effect; Reduced intensity stem cell transplantation

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CYCLOSPORIN; CYTOKINE; FLUDARABINE; FLUOROURACIL; METHOTREXATE; PREDNISOLONE; RECOMBINANT INTERLEUKIN 2; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KIDNEY CARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; SIDE EFFECT; SOLID TUMOR; SYMPTOM; TUMOR GROWTH;

BONE NEOPLASMS; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; FATAL OUTCOME; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 10744233655     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2003.00700.x     Document Type: Article

References (14)

1. Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 1979; 300: 1068-73.
2. van Besien KW, de Lima M, Giralt SA et al. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplant. 1997; 19: 977-82.
3. Eibl B, Schwaighofer H, Nachbaur D et al. Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer. Blood 1996; 88: 1501-8.
4. Childs R, Chemoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N. Engl. J. Med. 2000; 343: 750-8.
5. Styler MJ, Crilley P, Biggs J et al. Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis. Bone Marrow Transplant. 1996; 18: 171-6.
6. Lee CK, Haman GS, Hohl RJ, Gingrich RD. Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment. Bone Marrow Transplant. 1996; 18: 573-7.
7. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-62.
8. Collins RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol. 1997; 15: 433-44.
9. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-63.
10. Rini BI, Zimmerman T, Stadler WM, Gajewski TF, Vogelzang NJ. Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results. J. Clin. Oncol. 2002; 20: 2017-24.
11. Bregni M, Dodero A, Peccatori J et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood 2002; 99: 4234-6.
12. Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J. Urol. 2000; 163: 408-17.
13. Yagoda A. Chemotherapy of renal cell carcinoma: 1983-1989. Semin. Urol. 1989; 7: 199-206.
14. Negrier S, Escudier B, Usset C et al. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d'Immunotherapie. N. Engl. J. Med. 1998; 338: 1272-8.